Literature DB >> 16552790

Hy's law: predicting serious hepatotoxicity.

Robert Temple1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552790     DOI: 10.1002/pds.1211

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  97 in total

Review 1.  Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy.

Authors:  Shannan R Tujios; William M Lee
Journal:  Liver Int       Date:  2017-09-18       Impact factor: 5.828

2.  Answers to multiple choice questions.

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-12

3.  Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab' fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial.

Authors:  David Macfarlane; Angelides Socrates; Paul Eisenberg; George Larcos; Paul Roach; Michael Gerometta; Richard Smart; Wendy Tsui; Andrew M Scott
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-18       Impact factor: 9.236

4.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

5.  Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children.

Authors:  Linda Aurpibul; Torsak Bunupuradah; Sam Sophan; David Boettiger; Dewi K Wati; Lam V Nguyen; Vonthanak Saphonn; Rawiwan Hansudewechakul; Kulkanya Chokephaibulkit; Pagakrong Lumbiganon; Khanh H Truong; Viet C Do; Nagalingeswaran Kumarasamy; Nik K N Yusoff; Kamarul Razali; Nia Kurniati; Siew M Fong; Revathy Nallusamy; Annette H Sohn
Journal:  Pediatr Infect Dis J       Date:  2015-06       Impact factor: 2.129

6.  Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.

Authors:  Vincent Lo Re; Kevin Haynes; David Goldberg; Kimberly A Forde; Dena M Carbonari; Kimberly B F Leidl; Sean Hennessy; K Rajender Reddy; Pamala A Pawloski; Gregory W Daniel; T Craig Cheetham; Aarthi Iyer; Kara O Coughlin; Sengwee Toh; Denise M Boudreau; Nandini Selvam; William O Cooper; Mano S Selvan; Jeffrey J VanWormer; Mark I Avigan; Monika Houstoun; Gwen L Zornberg; Judith A Racoosin; Azadeh Shoaibi
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06-25       Impact factor: 2.890

Review 7.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

Review 8.  An Update on Drug-induced Liver Injury.

Authors:  Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 9.  Drug-induced acute liver failure.

Authors:  William M Lee
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

10.  Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.

Authors:  Patrick Lyden; Kent E Pryor; Christopher S Coffey; Merit Cudkowicz; Robin Conwit; Ashutosh Jadhav; Robert N Sawyer; Jan Claassen; Opeolu Adeoye; Shlee Song; Peter Hannon; Natalia S Rost; Archana Hinduja; Michel Torbey; Jin-Moo Lee; Curtis Benesch; Michael Rippee; Marilyn Rymer; Michael T Froehler; E Clarke Haley; Mark Johnson; Jon Yankey; Kim Magee; Julie Qidwai; Howard Levy; E Mark Haacke; Miller Fawaz; Thomas P Davis; Arthur W Toga; John H Griffin; Berislav V Zlokovic
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.